Iberdomide Versus Observation Off Therapy After Idecabtagene Vicleucel CAR-T for Multiple Myeloma

NCT06179888 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

78

Enrollment

NIH

Sponsor class

Conditions

Multiple Myeloma

Interventions

PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Computed Tomography
DRUG: Iberdomide
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: Patient Monitoring
PROCEDURE: Positron Emission Tomography
PROCEDURE: Skeletal Survey X-Ray

Sponsor

National Cancer Institute (NCI)